RNA Biology and Cancer
22° Simposio Pezcoller, Trento
Trento
The program of the Symposium has been developed by Dr Rene Bernards (National Cancer Institute, Amsterdam), Dr Witold Filipowicz (Friedrich Miescher Institute for Biomedical Research, Basel) and Dr David Livingston (Dana Farber Cancer Institute, Boston); they will co-chair the meeting in cooperation with Dr Enrico Mihich (Dana Farber Cancer Institute). The focus of the Symposium will be on the functional importance of various non-coding RNA molecules in cancer.
The topics to be discussed will include the opportunities offered by small RNA as tools for cancer drug development, the role of non-coding RNAs, the biochemistry of small RNAs, the function of micro-RNA in cancer, and RNAs as diagnostics and therapeutics in cancer. Each 30 minute talk by the 18 invited speakers will be followed by 25 minutes of discussion, thus providing ample opportunity for interaction and cross-fertilization among participants. A session of posters in the areas discussed at the Symposium will be included.
GENERAL INFORMATION:
Travel and local arrangements
Fondazione Alessio Pezcoller
Via Dordi, 8 - 38122 Trento (Italy)
Phone 0039-0461-980250
Fax 0039-0461-980350
E-mail: pezcoller@pezcoller.it
Scientific reference
David Livingston - Dana Farber Cancer Institute
david_livingston@dfci.harvard.edu
Tel 617-632-3074 Fax 617-632-4381, or
enrico_mihich@dfci.harvard.edu
Location
The Conference will be held at Conference Hall of Fondazione Cassa di Risparmio di Trento e Rovereto, Via Calepina, 1 - 38122, Trento (Italy)
Attendance at the meeting will be limited to a maximum of 100 participants.
Registration Fee
€200 (as a contribution to Symposium’s expenses) payable at the time of acceptance, directly to the symposium venue. The registration fee includes: participation to the symposium, congress kit, working lunches, coffee breaks, symposium dinner. For this event attendance credits have been requested.
Posters
A limited number of poster presentations will be accepted on a competitive basis. Pezcoller-Begnudelli Fellowships will be given to the 3 best posters. To submit a poster send a one-page abstract to Dr. Mihich (by 15 May, 2010).
E-mail: enrico_mihich@dfci.harvard.edu
Hotel accommodations (bed and breakfast)
H. America - Via Torre Verde € 68 (single room) Tel. 39 0461 983010
AlberMonaco - Via Torre d’Augusto € 60/90 (single/double room) Tel. 39 0461 983060
H. Venezia - P.za Duomo € 72 (double room) Tel. 39 0461 234559
H. Buonconsiglio - via Romagnosi € 95 (single room) Tel. 39 0461 272 888
H. Trento - Via Alfieri € 98 (single room) Tel. 39 0461 271000
H. Accademia - Via Colico €88 (single room) Tel. 39 0461 233600
All hotels are at walking distance from the conference hall.
| Programma 22 Simposio | Download |
– Reuven Agami,
The Netherlands Cancer Institute, Amsterdam, The Netherlands– Alan Ashworth, Breakthrough Research Centre, London, UK
– Rene Bernards, National Cancer Institute, Amsterdam, The Netherlands
– Irene Bozzoni, University of Rome La Sapienza, Rome Italy
– Dalia Cohen, Rosetta Genomics, Philadelphia, PA
– CarloCroce, Ohio State University, Columbus, OH
– Withold Filipowicz, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
– Manel Esteller, Spanish National Cancer Center, Madrid, Spain
– Scott Hammond, University of North Carolina, Chapel Hill, NC
– Gunther Hartmann, University of Bonn, Bonn, Germany
– Eva Hernando, New York University Langone Medical Center, New York, NY
– William Kaelin, Dana Farber Cancer Institute, Boston, MA
– Sakari Kaupinnen, Santaris Pharma a/s, Copenhagen, Denmark
– Wilhelm Krek, Institute of Cell Biology, Zurich, Switzerland
– Anna Krichevsky, Brigham and Women’s Hospital, Boston, MA
– Joachim Lingner, Swiss Institute for Experimental Cancer Research (ISREC), Lausanne, Switzerland
– David Livingston, Dana Farber Cancer Institute, Boston, MA
– Yi Liu, UT Southwestern Medical Ctr, Dallas, TX
– Gunter Meister, Max-Planck Institute of Biochemistry, Martinsried, Germany
– Enrico Mihich, Dana Farber Cancer Institute, Boston, MA
– Luigi Naldini, San Raffaele Telethon Institute for Gene Therapy (HSRTIGET), Milan, Italy
– Pier Paolo Pandolfi, Harvard Medical School, Boston, MA
– Marco Pierotti, Istituto Nazionale Tumori, Milan, Italy
– Carola Ponzetto, University of Torino, Torino, Italy
– Frank Slack, Yale University, New Haven, CT
– Nadia Zaffaroni, Istituto Nazionale Tumori, Milan, Italy
– Lars Zender, Hannover Medical School, Hannover, Germany